The Epidemiology of SARS-CoV-2 Delta Variant in Kurdistan Region/Iraq
Main Article Content
Abstract
Article Details
References
World Health Organization (WHO). Tracking SARS-CoV-2 Variants. Available online: https://www.who.int/en/activities/ tracking-SARS-CoV-2-variants/ (accessed on 20 January 2021).
Twohig, K.A.; Nyberg, T.; Zaidi, A.; Thelwall, S et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: A cohort study. Lancet Infect. Dis. 2021.
Bilgin S, Kurtkulagi O, Kahveci GB, Duman TT, Tel BMA. Millennium pandemic: a review of coronavirus disease (COVID-19). Exp Biomed Res. (2020) 3:117–25.
COVID C, Team R. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:343–6.
Balkhair AA. COVID-19 pandemic:A new chapter in the history of infectious diseases. Oman Med J. 2020;35:e12
Faris L, Hiba R, Hanan K, Sinan G.M. Firas A, Yousef S. K, Riyadh A.A , Asaad L. M, Sundarasen S, Chinna K et al. Iraq experience in handling the COVID-19 pandemic: implications of public health challenges and lessons learned for future epidemic preparedness planning. Journal of Public Health, Volume 43, Issue Supplement_3, December 2021, Pages iii19–iii28.
PongpirulA, Pongpirul K, Ratnarathon AC, Prasithsirikul W. Journey of a Thai taxi driver and novel coronavirus. N Engl J Med. (2020) 382:1067–8.
Russell, T.W.; Golding, N.; Hellewell, J.; Abbott, S.; Wright, L.; Pearson, C.A.; van Zandvoort, K.; Jarvis, C.I.; Gibbs, H.; Liu, Y.; et al. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC Med. 2020, 18, 1–9.
Pullano, G.; Di Domenico, L.; Sabbatini, C.E.; Valdano, E.; Turbelin, C.; Debin, M.; Guerrisi, C.; Kengne-Kuetche, C.; Souty, C.; Hanslik, T.; et al. Underdetection of cases of COVID-19 in France threatens epidemic control. Nature 2021, 590, 134–139
Yang, J.; Chen, X.; Deng, X.; Chen, Z et al. Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China. Nat. Commun. 2020, 11, 5411.
Budd, J.; Miller, B.S.; Manning, E.M et al. Digital technologies in the public-health response. Nat. Med. 2020, 26, 1183–1192.
Rambaut A, Holmes EC, O'Toole Á, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5(11):1403-7.
Lustig, Y.; Zuckerman, N.; Nemet, Iet al. Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel. Euro. Surveill. 2021, 26, 2100557.
Singh, J.; Rahman, S.A.; Ehtesham, N.Z.; Hira, S.; Hasnain, S.E. SARS-CoV-2 variants of concern are emerging in India. Nat. Med. 2021, 27, 1131–1133.
Callaway, E. Delta coronavirus variant: Scientists brace for impact. Nature 2021, 595, 17–18.
Mary Van Beusekom | News Writer | CIDRAP News | Jun 17, 2021. (2021, June 17). Youth, Delta variant behind UK covid surge. CIDRAP. Retrieved July 22, 2022, from https://www.cidrap.umn.edu/news-perspective/2021/06/youth-delta-variant-behind-uk-covid-surge
Liu, C. Ginn, H.M. Dejnirattisai, W. Supasa, P.; Wang, B. Tuekprakhon, A. Nutalai, R. Zhou, D. Mentzer, A.J. Zhao, Y. et al. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell 2021, 184, 4220–4236.e13.
Seppälä, E. Veneti, L. Starrfelt, J. Danielsen, A.S. Bragstad, K. Hungnes, O. Taxt, A.M. Watle, S.V. Meijerink, H. Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021. Euro. Surveill. 2021, 26, 2100793.
Lopez, J.; Andrews, N.; Gower, C.; Gallagher, E.; Simmons, R.; Thelwall, S.; Stowe, J.; Tessier, E.; Groves, N.; Dabrera, G.; et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N. Engl. J. Med. 2021, 385, 585–594.
Adam, S. L. associate professor1, Mark, W.T. James, D. C. Clinical Severity of and effectiveness of mRNA vaccines against omicron, delta and alpha SARS-CoV-2 variants in the united states: Prospective and observational study. BMJ. 2022; 376.
Sonabend, R.; Whittles, L.K.; Imai, N.; Perez-Guzman, P.N.; Knock, E.S.; Rawson, T.; Gaythorpe, K.A.M.; Djaafara, B.A.; Hinsley, W.; FitzJohn, R.G.; et al. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: A mathematical modelling study. Lancet 2021, 398, 1825–1835.
Abbreviations:VOC: variant of conver, WHO: World Health Organization, CDC: center of disease control.